KK
RLAY icon

KLP Kapitalforvaltning’s Relay Therapeutics RLAY Stock Holding History

KLP Kapitalforvaltning’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Hold
27,200
– – ﹤0.01% 1499
2026
Q1 		$271K Buy
27,200
+2,500
+10% +$22.4K ﹤0.01% 1704
2025
Q4 		$209K Hold
24,700
– – ﹤0.01% 1826
2025
Q3 		$129K Hold
24,700
– – ﹤0.01% 1991
2025
Q2 		$85.5K Hold
24,700
– – ﹤0.01% 2081
2025
Q1 		$64.7K Hold
24,700
– – ﹤0.01% 2155
2024
Q4 		$102K Buy
+24,700
New +$134K ﹤0.01% 2080

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

KLP Kapitalforvaltning's RLAY Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 27,200 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

KLP Kapitalforvaltning first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • KLP Kapitalforvaltning held 27,200 shares of Relay Therapeutics worth $509K as of Q2 2026.
  • KLP Kapitalforvaltning left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1499 holding.
  • KLP Kapitalforvaltning first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.